Physician profile
Nick Ho
NPI 1932325271
$2,322.74
in general payments reported to CMS, 2019-2025
19 companies · $666 in 2025
The $666 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.90 · 2020: $108 · 2021: $125 · 2022: $288 · 2023: $242 · 2024: $880 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,566 · Entertainment: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,566.09 |
| Entertainment | $221.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $383.46 | 2022-2025 | Total30, Dailies Total1, Precision 1 |
| Optos, INC. | $294.55 | 2020-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $205.78 | 2022-2024 | Miebo |
| Sun Pharmaceutical Industries INC. | $203.69 | 2025 | |
| Glaukos Corporation | $135.05 | 2025 | Photrexa Viscous and Photrexa |
| Abbvie INC. | $125.00 | 2023 | |
| Aerie Pharmaceuticals, INC. | $124.98 | 2021 | |
| Astellas Pharma US INC | $121.86 | 2025 | Izervay |
| Dompe US, INC. | $120.85 | 2024 | Oxervate |
| Biotissue Holdings INC. | $100.00 | 2024 | |
| Harrow Eye, LLC | $98.55 | 2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $94.25 | 2024 | Xdemvy |
| Coopervision INC. | $82.06 | 2024 | Misight Contact Lens, Biofinity Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $76.65 | 2022 | |
| Allergan, INC. | $57.93 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $48.74 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Carl Zeiss Meditec Ag | $17.20 | 2020 | |
| Eyevance Pharmaceuticals LLC | $14.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nick Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.